Open access peer-reviewed chapter

Midkine Signaling in Glioblastoma: A Novel Developmental Drug Target?

By Ayhan Bilir and Mine Erguven

Submitted: November 8th 2010Reviewed: April 10th 2011Published: September 22nd 2011

DOI: 10.5772/20372

Downloaded: 1250

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Ayhan Bilir and Mine Erguven (September 22nd 2011). Midkine Signaling in Glioblastoma: A Novel Developmental Drug Target?, Management of CNS Tumors Miklos Garami, IntechOpen, DOI: 10.5772/20372. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/management-of-cns-tumors/midkine-signaling-in-glioblastoma-a-novel-developmental-drug-target-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1250total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Blood-Brain Barrier in Brain Tumours

By Susan Noell, Karen Wolburg-Buchholz, Andreas F. Mack, Hartwig Wolburg and Petra Fallier-Becker

Related Book

First chapter

Genetic and Immunology of Brain Tumors

By Sahika Liva Cengiz and Aynur Emine Cicekcibasi

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us